{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:30:13Z","timestamp":1771259413020,"version":"3.50.1"},"reference-count":7,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"DOI":"10.1111\/bjd.16698","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T06:36:46Z","timestamp":1524811006000},"source":"Crossref","is-referenced-by-count":6,"title":["Angiosarcoma of the scalp responding to nivolumab: a case report"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0831-2098","authenticated-orcid":false,"given":"S.","family":"Hofer","sequence":"first","affiliation":[{"name":"Division of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Zeidler","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schipf","sequence":"additional","affiliation":[{"name":"Department of Pathology; Luzerner Kantonsspital; Luzern 6000 Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Kempf","sequence":"additional","affiliation":[{"name":"Pathology Kempf & Pfalz; Z\u00fcrich Switzerland"},{"name":"Department of Dermatopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathology; University Hospital Z\u00fcrich; Z\u00fcrich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Aebi","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"10.1111\/bjd.16698-BIB0001|bjd16698-cit-0001","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","article-title":"Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1111\/bjd.16698-BIB0002|bjd16698-cit-0002","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40425-017-0263-0","article-title":"Angiosarcoma treated successfully with anti-PD-1 therapy - a case report","volume":"5","author":"Sindhu","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1111\/bjd.16698-BIB0003|bjd16698-cit-0003","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/annonc\/mdw289","article-title":"Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer","volume":"27","author":"Mansfield","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.16698-BIB0004|bjd16698-cit-0004","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature24473","article-title":"A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy","volume":"551","author":"\u0141uksza","year":"2017","journal-title":"Nature"},{"key":"10.1111\/bjd.16698-BIB0005|bjd16698-cit-0005","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/cncr.30726","article-title":"T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas","volume":"123","author":"Pollack","year":"2017","journal-title":"Cancer"},{"key":"10.1111\/bjd.16698-BIB0006|bjd16698-cit-0006","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jamaoncol.2016.2450","article-title":"Classification of advanced human cancers based on Tumor Immunity in the MicroEnvironment (TIME) for cancer immunotherapy","volume":"2","author":"Zhang","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1111\/bjd.16698-BIB0007|bjd16698-cit-0007","doi-asserted-by":"crossref","first-page":"e1253657","DOI":"10.1080\/2162402X.2016.1253657","article-title":"Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma","volume":"6","author":"Honda","year":"2016","journal-title":"Oncoimmunology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16698","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16698\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:41:16Z","timestamp":1676382076000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/2\/530\/6730867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":7,"URL":"https:\/\/doi.org\/10.1111\/bjd.16698","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,13]]}}}